Zachary Zinn is a Dermatology physician affiliated with West Virginia University. OpenAlex indexes 69 publications with 598 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Stadium Dr Ste 3
Morgantown, WV 265067900
Telephone
304-598-4865Registry record last updated 26 Jun 2013.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alexion Pharmaceuticals, Inc.Program year20254 payments
- Journey Medical CorporationProgram year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
30.9%Tetracycline-class Drug30.9%Doxycycline Hyclate100%Part D<11 patientsAntiparasitic
25.5%Antimalarial25.5%Hydroxychloroquine Sulfate100%Part D<11 patientsSensory organs
23.6%Corticosteroid23.6%Clobetasol Propionate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Limitations and risks of custom GPTs in dermatology. Comment on “ReconGPT: A novel artificial intelligence tool and its potential use in post-Mohs reconstructive decision-making”
Journal of the American Academy of Dermatology
2025 - Dominant dystrophic epidermolysis bullosa across three distinct skin types
Journal of the American Academy of Dermatology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Stephen Wetmore, MD, MBS, FACS
West Virginia University
Jerome Saul, MD
West Virginia University
Timothy Deer, MD
West Virginia University
Lucinda England, MD
West Virginia University
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”